Evidence map›Paper›PMID 31741351›Full record

ArticleJournal of biomedical optics2019

Verteporfin- and sodium porfimer-mediated photodynamic therapy enhances pancreatic cancer cell death without activating stromal cells in the microenvironment.

Jingjing Lu, Bhaskar Roy, Marlys Anderson, Cadman L Leggett, Michael J Levy, Brian Pogue, Tayyaba Hasan, Kenneth K Wang

Open access · goldAbstract read
In one paragraph

Article in Journal of biomedical optics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
3.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Necroptosis activation is associated with greater methylene blue-photodynamic therapy-induced cytotoxicity in human pancreatic ductal adenocarcinoma cells.Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology · 2023
    Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Effect of Cerenkov Radiation-Induced Photodynamic Therapy withInternational journal of molecular sciences · 2021
    Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Jingjing LuMayo Clinic and Foundation, Barrett's Esophagus Unit, Division of Gastroenterology and Hepatology, R, United States.
Bhaskar RoyMayo Clinic and Foundation, Barrett's Esophagus Unit, Division of Gastroenterology and Hepatology, R, United States.
Marlys AndersonMayo Clinic and Foundation, Barrett's Esophagus Unit, Division of Gastroenterology and Hepatology, R, United States.
Cadman L LeggettMayo Clinic and Foundation, Barrett's Esophagus Unit, Division of Gastroenterology and Hepatology, R, United States.
Michael J LevyMayo Clinic and Foundation, Barrett's Esophagus Unit, Division of Gastroenterology and Hepatology, R, United States.
Brian PogueDartmouth College, Thayer School of Engineering, Hanover, New Hampshire, United States.
Tayyaba HasanHarvard School of Medicine, Massachusetts General Hospital, Boston, Massachusetts, United States.
Kenneth K WangMayo Clinic and Foundation, Barrett's Esophagus Unit, Division of Gastroenterology and Hepatology, R, United States.
WinnMed · USDartmouth College · USMassachusetts General Hospital · USPeking University Third Hospital · CN

Funding

Small Molecule Enhancers of Photodynamic Therapy for Skin CancerP01CA084203 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI Bryan Quilty Spring · 2001 to 2026
$27.9M
NCI NIH HHS P01 CA084203
6 · The paper itself

Abstract

The goal of our study was to determine the susceptibility of different pancreatic cell lines to clinically applicable photodynamic therapy (PDT). The efficacy of PDT of two different commercially available photosensitizers, verteporfin and sodium porfimer, was compared using a panel of four different pancreatic cancer cell lines, PANC-1, BxPC-3, CAPAN-2, and MIA PaCa-2, and an immortalized non-neoplastic pancreatic ductal epithelium cell line, HPNE. The minimum effective concentrations and dose-dependent curves of verteporfin and sodium porfimer on PANC-1 were determined. Since pancreatic cancer is known to have significant stromal components, the effect of PDT on stromal cells was also assessed. To mimic tumor-stroma interaction, a co-culture of primary human fibroblasts or human pancreatic stellate cell (HPSCs) line with PANC-1 was used to test verteporfin-PDT-mediated cell death of PANC-1. Two cytokines (TNF-α and IL-1β) were used for stimulation of primary fibroblasts (derived from human esophageal biopsies) or HPSCs. The increased expression of smooth muscle actin (α-SMA) confirmed the activation of fibroblasts or HPSC upon treatment with TNF-α and IL-1β. Cell death assays showed that both sodium porfimer- and verteporfin-mediated PDT-induced cell death in a dose-dependent manner. However, verteporfin-PDT treatment had a greater efficiency with 60  ×   lower concentration than sodium porfimer-PDT in the PANC-1 incubated with stimulated fibroblasts or HPSC. Moreover, activation of stromal cells did not affect the treatment of the pancreatic cancer cell lines, suggesting that the effects of PDT are independent of the inflammatory microenvironment found in this two-dimensional culture model of cancers.

Indexed as

PhotochemotherapyBiopsyCell DeathCell Line, TumorCoculture TechniquesDihematoporphyrin EtherDrug Screening Assays, AntitumorFibroblastsHumansMicroscopy, FluorescencePancreasPancreatic NeoplasmsStromal CellsTumor MicroenvironmentVerteporfinDihematoporphyrin EtherVerteporfinfibroblastpancreatic cancerphotodynamic therapyphotosensitizersodium porfimerverteporfin

Identifiers

PMID31741351
PMCPMC7003148
OpenAlexW2983415563

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.